Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

1999, Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, Lancet, 354, 716, 10.1016/S0140-6736(99)07403-6 White, 1998, Thrombolysis for acute myocardial infarction, Circulation, 97, 1632, 10.1161/01.CIR.97.16.1632 Armstrong, 2001, Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion, part I, Circulation, 103, 2865 Turpie, 2001, Low molecular weight heparins in the treatment of acute coronary syndromes, Arch Intern Med, 161, 1484, 10.1001/archinte.161.12.1484 Ross, 2001, A randomized comparison of low-molecular-weight heparin enoxaparin and unfractionated heparin adjunctive to t-PA thrombolysis and aspirin (HART II), Circulation, 104, 648, 10.1161/hc3101.093866 Simoons ML, Alonso A, Krzeminska-Pakula M, et al. Early ST segment elevation resolution: predictor of outcome and angiographic patency in patients with acute myocardial infarction. Results of the AMI-SK study. Eur Heart J (in press). Baird, 1998, LMWH versus unfractionated heparin following thrombolysis in myocardial infarction, J Am Coll Cardiol, 31, 191A, 10.1016/S0735-1097(97)84538-X Wallentin, 2001, The low-molecular-10 weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT Plus study, Clin Cardiol, 24, I12, 10.1002/clc.4960241305 Antman, 1999, Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial, Circulation, 99, 2720, 10.1161/01.CIR.99.21.2720 2000, Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction, Circulation, 101, 2788, 10.1161/01.CIR.101.24.2788 Brener, 1999, INTRO AMI: marked enhancement of arterial patency with eptifibatide and low-dose t-PA in acute myocardial infarction, Circulation, 100, 1 2001, Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial, Lancet, 357, 1905, 10.1016/S0140-6736(00)05059-5 Ryan, 1999, Circulation, 100, 1016, 10.1161/01.CIR.100.9.1016 Giugliano, 2001, Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial haemorrhage, Am Heart J, 141, 742, 10.1067/mhj.2001.114975